Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial

作者
Amit X. Garg,Meaghan S. Cuerden,Héctor J. Aguado,Mohammed Amir,Emilie P. Belley‐Côté,Keyur Bhatt,Bruce McClure Biccard,Flávia K. Borges,Matthew T.V. Chan,David Conen,Emmanuelle Duceppe,Sergey Mihailovich Efremov,John W. Eikelboom,Edith Fleischmann,Giovanni Landoni,Peter L. Gross,Raja Jayaram,М. Yu. Кirov,Ydo Vincent Kleinlugtenbelt,Andrea M. Kurz
出处
期刊:Canadian journal of kidney health and disease [SAGE Publishing]
卷期号:9: 20543581211069225-20543581211069225 被引量:6
标识
DOI:10.1177/20543581211069225
摘要

BACKGROUND: Most patients who take antihypertensive medications continue taking them on the morning of surgery and during the perioperative period. However, growing evidence suggests this practice may contribute to perioperative hypotension and a higher risk of complications. This protocol describes an acute kidney injury substudy of the Perioperative Ischemic Evaluation-3 (POISE-3) trial, which is testing the effect of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy in patients undergoing noncardiac surgery. OBJECTIVE: To conduct a substudy of POISE-3 to determine whether a perioperative hypotension-avoidance strategy reduces the risk of acute kidney injury compared with a hypertension-avoidance strategy. DESIGN: Randomized clinical trial with 1:1 randomization to the intervention (a perioperative hypotension-avoidance strategy) or control (a hypertension-avoidance strategy). INTERVENTION: If the presurgery systolic blood pressure (SBP) is <130 mmHg, all antihypertensive medications are withheld on the morning of surgery. If the SBP is ≥130 mmHg, some medications (but not angiotensin receptor blockers [ACEIs], angiotensin receptor blockers [ARBs], or renin inhibitors) may be continued in a stepwise manner. During surgery, the patients' mean arterial pressure (MAP) is maintained at ≥80 mmHg. During the first 48 hours after surgery, some antihypertensive medications (but not ACEIs, ARBs, or renin inhibitors) may be restarted in a stepwise manner if the SBP is ≥130 mmHg. CONTROL: Patients receive their usual antihypertensive medications before and after surgery. The patients' MAP is maintained at ≥60 mmHg from anesthetic induction until the end of surgery. SETTING: Recruitment from 108 centers in 22 countries from 2018 to 2021. PATIENTS: Patients (~6800) aged ≥45 years having noncardiac surgery who have or are at risk of atherosclerotic disease and who routinely take antihypertensive medications. MEASUREMENTS: The primary outcome of the substudy is postoperative acute kidney injury, defined as an increase in serum creatinine concentration of either ≥26.5 μmol/L (≥0.3 mg/dL) within 48 hours of randomization or ≥50% within 7 days of randomization. METHODS: . RESULTS: Substudy results will be analyzed in 2022. LIMITATIONS: It is not possible to mask patients or providers to the intervention; however, objective measures will be used to assess acute kidney injury. CONCLUSIONS: This substudy will provide generalizable estimates of the effect of a perioperative hypotension-avoidance strategy on the risk of acute kidney injury.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏的应助被微微采纳,获得10
刚刚
1秒前
沉淀发布了新的文献求助10
1秒前
小星星完成签到,获得积分20
1秒前
1秒前
香蕉觅云的应助被彭佳丽采纳,获得10
1秒前
1秒前
2秒前
DXY完成签到,获得积分10
2秒前
ling发布了新的文献求助10
2秒前
不想起名字完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
sjx发布了新的文献求助10
3秒前
4秒前
杨濮帆发布了新的文献求助10
4秒前
4秒前
Xyy完成签到,获得积分10
4秒前
YPHCC发布了新的文献求助10
5秒前
5秒前
LLL发布了新的文献求助10
6秒前
6秒前
6秒前
jx发布了新的文献求助10
6秒前
林读书发布了新的文献求助10
6秒前
辞星完成签到,获得积分10
6秒前
7秒前
7秒前
8秒前
8秒前
Chen_Y发布了新的文献求助10
8秒前
沉淀完成签到,获得积分10
8秒前
核桃发布了新的文献求助10
8秒前
乐乐的应助被辛勤夜安采纳,获得10
8秒前
wang完成签到,获得积分10
9秒前
今后的应助被lululiya采纳,获得10
9秒前
zvvx完成签到,获得积分10
9秒前
9秒前
Ava的应助被houxiyang采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182453
求助须知:如何正确求助?哪些是违规求助? 9571953
关于积分的说明 21821007
捐赠科研通 7778889
什么是DOI,文献DOI怎么找? 3433670
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479704